wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34139793-51841A0F-D11A-42B0-BA06-34915025D067
Q34139793-51841A0F-D11A-42B0-BA06-34915025D067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34139793-51841A0F-D11A-42B0-BA06-34915025D067
Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.
P2860
Q34139793-51841A0F-D11A-42B0-BA06-34915025D067
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34139793-51841A0F-D11A-42B0-BA06-34915025D067
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e27583ff9d8dba43450720dcb8bc0b1a1897dc8c
P2860
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.